Stock Screener App

Frei -

Installieren

79.61

1.35% 1.06

after-market

Handel nachbörslich: 79.61

Dianthus Therapeutics Inc (DNTH)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	28.28% 0.284	0.396	0.193	1.163	1.326
Operating Expenses	71.63% 69.83	40.68	35.12	34.34	33.24
Benefits Costs and Expenses	64.72	-	-	30.67	29.77
Costs And Expenses	59.07% 64.72	40.68	35.12	30.67	16.35
Operating Income/Loss	72.61% -69.54	-40.29	-34.93	-33.18	-31.92
Nonoperating Income/Loss	45.02% 5.109	3.523	3.298	3.666	3.476
Income/Loss From Continuing Operations Before Tax	16,371% -64.43	0.396	-31.63	-29.51	-28.44
Income/Loss From Continuing Operations After Tax	75.25% -64.43	-36.77	-31.63	-29.51	-28.44
Net Income/Loss	75.25% -64.43	-36.77	-31.63	-29.51	-28.44
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.33% 2.1412	37.79	35.82	35.79	0.6991
Diluted Average Shares	94.33% 2.1412	37.79	35.82	35.79	0.6991
Basic Earnings Per Share	56.70% -1.52	-0.97	-0.88	-0.82	-0.82
Diluted Earnings Per Share	56.70% -1.52	-0.97	-0.88	-0.82	-0.82
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters